The global cerebral oximetry monitoring market size is expected to reach USD 354.68 billion by 2030, registering a compound annual growth rate (CAGR) of 7.2% during the forecast period. The key factors driving the growth of the market are the increasing incidence of critical heart illness. According to the Centers for Disease Control and Prevention (CDC), about 1 in 110 births in the U.S. have congenital heart disease (CHD), and 25% of this total CHD births are considered critical CHD. This CCHD patient requires intervention soon after birth to prevent significant mortality; later infant detection increases the risk of brain damage.
Traditionally, the diagnosis of CCHD in infants was made with the observation of evidence of CCHD physical assessment and monitoring for common symptoms. Still, several research studies showed that this traditional method could be unreliable and fail to detect new infants with CCHD. Adding cerebral oximetry screening can help physicians identify CCHD patients before an infant becomes symptomatic. For instance, in November 2021, Masimo launched “Dual SET Oximetry” to screen infant patients with CCHD. This launch is expected to drive market growth over the forecast period.
Furthermore, several strategic initiatives are undertaken by major players, such as collaboration, partnership, and licensing agreements, to strengthen their product portfolio and expand their business presence. For instance, in May 2020, Koninklijke Philips N.V. and Masimo signed a licensing agreement to reinforce their partnership by additional integration of Masimo measurement technologies into select Intellivue Mx-series multi-parameter monitors. This technology integration helps physicians evaluate the patient's ventilation and cerebral oximetry status.
The COVID-19 pandemic negatively affected the global cerebral oximetry monitoring market due to decreased outpatient visits and a dramatic reduction in essential and non-essential surgeries. For instance, according to a 2021 research study by the Journal of Cardiothoracic Surgery, cardiac surgery decreased by 50 to 70% during the COVID-19 pandemic. Over 50% reduction was seen in ICU beds and cardiac theatre rooms. However, it is anticipated that post-COVID pandemic hospitals may witness high patient visits after the opening of the economy and the normalization of Covid-19 regulations.
This product will be delivered within 1-3 business days.
Traditionally, the diagnosis of CCHD in infants was made with the observation of evidence of CCHD physical assessment and monitoring for common symptoms. Still, several research studies showed that this traditional method could be unreliable and fail to detect new infants with CCHD. Adding cerebral oximetry screening can help physicians identify CCHD patients before an infant becomes symptomatic. For instance, in November 2021, Masimo launched “Dual SET Oximetry” to screen infant patients with CCHD. This launch is expected to drive market growth over the forecast period.
Furthermore, several strategic initiatives are undertaken by major players, such as collaboration, partnership, and licensing agreements, to strengthen their product portfolio and expand their business presence. For instance, in May 2020, Koninklijke Philips N.V. and Masimo signed a licensing agreement to reinforce their partnership by additional integration of Masimo measurement technologies into select Intellivue Mx-series multi-parameter monitors. This technology integration helps physicians evaluate the patient's ventilation and cerebral oximetry status.
The COVID-19 pandemic negatively affected the global cerebral oximetry monitoring market due to decreased outpatient visits and a dramatic reduction in essential and non-essential surgeries. For instance, according to a 2021 research study by the Journal of Cardiothoracic Surgery, cardiac surgery decreased by 50 to 70% during the COVID-19 pandemic. Over 50% reduction was seen in ICU beds and cardiac theatre rooms. However, it is anticipated that post-COVID pandemic hospitals may witness high patient visits after the opening of the economy and the normalization of Covid-19 regulations.
Cerebral Oximetry Monitoring Market Report Highlights
- Adults accounted for the largest share of the 67.34% age group segment in 2022. The dominance can be attributed to the increased number of adult patients with cardiac morbidities
- Based on application, cardiac surgery is anticipated to register the fastest CAGR growth during the forecast period
- The hospitals & clinics segment accounted for the largest share of 52.55% in 2022. The increasing number of inpatients and outpatients visits for various disease consultations and treatment
- North America accounted for the largest share of 37.41% in 2022. The growing prevalence of non-communicable diseases and rising developments in cerebral oximetry devices are the key factors driving market growth in the region
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope1.1. Market Segmentation & Scope
1.1.1. Segment Scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cerebral Oximetry Monitoring Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Cerebral Oximetry Monitoring: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Major Deals & Strategic Alliances Analysis
3.3.4. COVID-19 Impact Analysis
Chapter 4. Cerebral Oximetry Monitoring Market: Application Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Cardiac Surgery
4.1.2. Vascular Surgery
4.1.3. Others
4.2. Cerebral Oximetry Monitoring Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Cerebral Oximetry Monitoring Market by Application Outlook
4.5. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
4.5.1. Cardiac Surgery
4.5.1.1. Cardiac Surgery Cerebral Oximetry Monitoring Market 2018 to 2030 (USD Million)
4.5.2. Vascular Surgery
4.5.2.1. Vascular Surgery Cerebral Oximetry Monitoring Market 2018 to 2030 (USD Million)
4.5.3. Others
4.5.3.1. Others Cerebral Oximetry Monitoring Market 2018 to 2030 (USD Million)
Chapter 5. Cerebral Oximetry Monitoring Market: Age Group Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Pediatric
5.1.2. Adult
5.2. Cerebral Oximetry Monitoring Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Cerebral Oximetry Monitoring Market by Age Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Pediatric
5.5.1.1. Pediatric Cerebral Oximetry Monitoring Market 2018 to 2030 (USD Million)
5.5.2. Adult
5.5.2.1. Adult Cerebral Oximetry Monitoring Market 2018 to 2030 (USD Million)
Chapter 6. Cerebral Oximetry Monitoring Market: End Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals & Clinics
6.1.2. Ambulatory Surgical centers
6.1.3. Others
6.2. Cerebral Oximetry Monitoring Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Cerebral Oximetry Monitoring Market by End-Use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals & Clinics Cerebral Oximetry Monitoring Market 2018 to 2030 (USD Million)
6.5.2. Ambulatory Surgical centers
6.5.2.1. Ambulatory Surgical centers Cerebral Oximetry Monitoring Market 2018 to 2030 (USD Million)
6.5.3. Others
6.5.3.1. Others Cerebral Oximetry Monitoring Market 2018 to 2030 (USD Million)
Chapter 7. Cerebral Oximetry Monitoring Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. U.S. Cerebral Oximetry Monitoring Market/, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Canada Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. U.K.
7.4.1.1. U.K. Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Germany Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.4.3. France
7.4.3.1. France Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Italy Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Spain Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.4.6. Denmark
7.4.6.1. Denmark Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Sweden Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.4.8. Norway
7.4.8.1. Norway Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Japan Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.5.2. China
7.5.2.1. China Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.5.3. India
7.5.3.1. India Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Australia Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.5.5. Thailand
7.5.5.1. Thailand Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.5.6. South Korea
7.5.6.1. South Korea Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Brazil Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.6.2. Mexico
7.6.2.1. Mexico Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Argentina Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. South Africa Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Saudi Arabia Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.7.3. UAE
7.7.3.1. UAE Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Kuwait Cerebral Oximetry Monitoring Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Profiles
8.1.1. Masimo
8.1.1.1. Company overview
8.1.1.2. Financial Performance
8.1.1.3. Product benchmarking
8.1.1.4. Strategic initiatives
8.1.2. Medtronic
8.1.2.1. Company overview
8.1.2.2. Financial performance
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. Edwards Lifesciences Corporation
8.1.3.1. Company overview
8.1.3.2. Financial performance
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Nonin
8.1.4.1. Company overview
8.1.4.2. Financial performance
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. ISS Inc.
8.1.5.1. Company overview
8.1.5.2. Financial performance
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. Hamamatsu Photonics K.K.
8.1.6.1. Company overview
8.1.6.2. Financial performance
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. Mespere LifeSciences
8.1.7.1. Company overview
8.1.7.2. Financial performance
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. G.E. Healthcare
8.1.8.1. Company overview
8.1.8.2. Financial performance
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Terumo Cardiovascular Systems Corporation
8.1.9.1. Company overview
8.1.9.2. Financial performance
8.1.9.3. Product benchmarking
8.1.9.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global cerebral oximetry monitoring market, by application, 2018 - 2030 (USD Million)
Table 4 Global cerebral oximetry monitoring market, by age group, 2018 - 2030 (USD Million)
Table 5 Global cerebral oximetry monitoring market, by end-use, 2018 - 2030 (USD Million)
Table 6 Global cerebral oximetry monitoring market, by region, 2018 - 2030 (USD Million)
Table 7 Participant’s overview
Table 8 Financial performance
Table 9 Key companies undergoing collaboration
Table 10 Key companies undergoing partnership
Table 11 Key companies undergoing expansion
Table 12 Key companies launching new launches
Table 13 Key companies undertaking other strategies
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market research approaches
Fig. 4 QFD modelling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Market Snapshot
Fig. 8 Segment Snapshot
Fig. 9 Segment Snapshot
Fig. 10 Competitive Landscape Snapshot
Fig. 11 Cerebral Oximetry Monitoring market segmentation
Fig. 12 Parent market outlook (2022)
Fig. 13 Related/ancillary market outlook (2022)
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Current shared services and outsourcing usage levels
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Porter’s five forces analysis
Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 19 Cerebral oximetry monitoring market application outlook: Segment dashboard
Fig. 20 Cerebral oximetry monitoring: application movement analysis
Fig. 21 Cardiac surgery market, 2018 - 2030 (USD Million)
Fig. 21 Vascular surgery market, 2018 - 2030 (USD Million)
Fig. 22 Others market, 2018 - 2030 (USD Million)
Fig. 23 Cerebral oximetry monitoring market age group outlook: Segment dashboard
Fig. 24 Cerebral oximetry monitoring market: Age group movement analysis
Fig. 25 Pediatric market, 2018 - 2030 (USD Million)
Fig. 26 Adult market, 2018 - 2030 (USD Million)
Fig. 27 Cerebral oximetry monitoring market end use outlook: Segment dashboard
Fig. 28 Cerebral oximetry monitoring market: end use movement analysis
Fig. 29 Hospitals & clinics market, 2018 - 2030 (USD Million)
Fig. 30 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
Fig. 31 Others market, 2018 - 2030 (USD Million)
Fig. 32 Regional marketplace: Segment dashboard
Fig. 33 Regional outlook, 2022 & 2030
Fig. 34 North America market, 2018 - 2030 (USD Million)
Fig. 35 U.S. market, 2018 - 2030 (USD Million)
Fig. 36 Canada market, 2018 - 2030 (USD Million)
Fig. 37 Europe market, 2018 - 2030 (USD Million)
Fig. 38 Germany market, 2018 - 2030 (USD Million)
Fig. 39 U.K. market, 2018 - 2030 (USD Million)
Fig. 40 France market, 2018 - 2030 (USD Million)
Fig. 41 Italy market, 2018 - 2030 (USD Million)
Fig. 42 Spain market, 2018 - 2030 (USD Million)
Fig. 43 Denmark market, 2018 - 2030(USD Million)
Fig. 44 Sweden market, 2018 - 2030 (USD Million)
Fig. 45 Norway market, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 47 China market, 2018 - 2030 (USD Million)
Fig. 48 Japan market, 2018 - 2030 (USD Million)
Fig. 49 India market, 2018 - 2030 (USD Million)
Fig. 50 Australia market, 2018 - 2030 (USD Million)
Fig. 51 South Korea market, 2018 - 2030 (USD Million)
Fig. 52 Latin America market, 2018 - 2030 (USD Million)
Fig. 53 Brazil market, 2018 - 2030 (USD Million)
Fig. 54 Mexico market, 2018 - 2030 (USD Million)
Fig. 55 Argentina market, 2018 - 2030 (USD Million)
Fig. 56 MEA market, 2018 - 2030 (USD Million)
Fig. 57 South Africa market, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 59 UAE market, 2018 - 2030 (USD Million)
Fig. 60 Kuwait market, 2018 - 2030 (USD Million)
Companies Mentioned
- Masimo
- Medtronic
- Edwards Lifesciences Corporation
- Nonin
- ISS Inc.
- Hamamatsu Photonics K.K.
- Mespere LifeSciences
- G.E. Healthcare
- Terumo Cardiovascular Systems Corporation
Methodology
LOADING...
